3-Deazaneplanocin A and neplanocin A analogues and their effects on apoptotic cell death. 2015

Eric K W Tam, and Tuan Minh Nguyen, and Cheryl Z H Lim, and Puay Leng Lee, and Zhimei Li, and Xia Jiang, and Sridhar Santhanakrishnan, and Tiong Wei Tan, and Yi Ling Goh, and Sze Yue Wong, and Haiyan Yang, and Esther H Q Ong, and Jeffrey Hill, and Qiang Yu, and Christina L L Chai
Institute of Chemical & Engineering Sciences, Agency for Science, Technology & Research (A*STAR), 8 Biomedical Grove, Neuros #07-01, Singapore 138665 (Singapore).

3-Deazaneplanocin A (DzNep) is a potential epigenetic drug for the treatment of various cancers. DzNep has been reported to deplete histone methylations, including oncogenic EZH2 complex, giving rise to epigenetic modifications that reactivate many silenced tumor suppressors in cancer cells. Despite its promise as an anticancer drug, little is known about the structure-activity relationships of DzNep in the context of epigenetic modifications and apoptosis induction. In this study, a number of analogues of DzNep were examined for DzNep-like ability to induce synergistic apoptosis in cancer cells in combination with trichostatin A, a known histone deacetylase (HDAC) inhibitor. The structure-activity relationship data thus obtained provide valuable information on the structural requirements for biological activity. The studies identified three compounds that show similar activities to DzNep. Two of these compounds show good pharmacokinetics and safety profiles. Attempts to correlate the observed synergistic apoptotic activities with measured S-adenosylhomocysteine hydrolase (SAHH) inhibitory activities suggest that the apoptotic activity of DzNep might not be directly due to its inhibition of SAHH.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000241 Adenosine A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. Adenocard,Adenoscan
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014183 Transplantation, Heterologous Transplantation between animals of different species. Xenotransplantation,Heterograft Transplantation,Heterografting,Heterologous Transplantation,Xenograft Transplantation,Xenografting,Transplantation, Heterograft,Transplantation, Xenograft
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis

Related Publications

Eric K W Tam, and Tuan Minh Nguyen, and Cheryl Z H Lim, and Puay Leng Lee, and Zhimei Li, and Xia Jiang, and Sridhar Santhanakrishnan, and Tiong Wei Tan, and Yi Ling Goh, and Sze Yue Wong, and Haiyan Yang, and Esther H Q Ong, and Jeffrey Hill, and Qiang Yu, and Christina L L Chai
August 1989, Antimicrobial agents and chemotherapy,
Eric K W Tam, and Tuan Minh Nguyen, and Cheryl Z H Lim, and Puay Leng Lee, and Zhimei Li, and Xia Jiang, and Sridhar Santhanakrishnan, and Tiong Wei Tan, and Yi Ling Goh, and Sze Yue Wong, and Haiyan Yang, and Esther H Q Ong, and Jeffrey Hill, and Qiang Yu, and Christina L L Chai
October 2019, Bioorganic & medicinal chemistry letters,
Eric K W Tam, and Tuan Minh Nguyen, and Cheryl Z H Lim, and Puay Leng Lee, and Zhimei Li, and Xia Jiang, and Sridhar Santhanakrishnan, and Tiong Wei Tan, and Yi Ling Goh, and Sze Yue Wong, and Haiyan Yang, and Esther H Q Ong, and Jeffrey Hill, and Qiang Yu, and Christina L L Chai
November 2003, Organic letters,
Eric K W Tam, and Tuan Minh Nguyen, and Cheryl Z H Lim, and Puay Leng Lee, and Zhimei Li, and Xia Jiang, and Sridhar Santhanakrishnan, and Tiong Wei Tan, and Yi Ling Goh, and Sze Yue Wong, and Haiyan Yang, and Esther H Q Ong, and Jeffrey Hill, and Qiang Yu, and Christina L L Chai
January 1991, Nucleic acids symposium series,
Eric K W Tam, and Tuan Minh Nguyen, and Cheryl Z H Lim, and Puay Leng Lee, and Zhimei Li, and Xia Jiang, and Sridhar Santhanakrishnan, and Tiong Wei Tan, and Yi Ling Goh, and Sze Yue Wong, and Haiyan Yang, and Esther H Q Ong, and Jeffrey Hill, and Qiang Yu, and Christina L L Chai
September 1996, Journal of medicinal chemistry,
Eric K W Tam, and Tuan Minh Nguyen, and Cheryl Z H Lim, and Puay Leng Lee, and Zhimei Li, and Xia Jiang, and Sridhar Santhanakrishnan, and Tiong Wei Tan, and Yi Ling Goh, and Sze Yue Wong, and Haiyan Yang, and Esther H Q Ong, and Jeffrey Hill, and Qiang Yu, and Christina L L Chai
September 2007, EMBO reports,
Eric K W Tam, and Tuan Minh Nguyen, and Cheryl Z H Lim, and Puay Leng Lee, and Zhimei Li, and Xia Jiang, and Sridhar Santhanakrishnan, and Tiong Wei Tan, and Yi Ling Goh, and Sze Yue Wong, and Haiyan Yang, and Esther H Q Ong, and Jeffrey Hill, and Qiang Yu, and Christina L L Chai
August 1994, Chemical & pharmaceutical bulletin,
Eric K W Tam, and Tuan Minh Nguyen, and Cheryl Z H Lim, and Puay Leng Lee, and Zhimei Li, and Xia Jiang, and Sridhar Santhanakrishnan, and Tiong Wei Tan, and Yi Ling Goh, and Sze Yue Wong, and Haiyan Yang, and Esther H Q Ong, and Jeffrey Hill, and Qiang Yu, and Christina L L Chai
January 1983, Nucleic acids symposium series,
Eric K W Tam, and Tuan Minh Nguyen, and Cheryl Z H Lim, and Puay Leng Lee, and Zhimei Li, and Xia Jiang, and Sridhar Santhanakrishnan, and Tiong Wei Tan, and Yi Ling Goh, and Sze Yue Wong, and Haiyan Yang, and Esther H Q Ong, and Jeffrey Hill, and Qiang Yu, and Christina L L Chai
January 1987, Journal of medicinal chemistry,
Eric K W Tam, and Tuan Minh Nguyen, and Cheryl Z H Lim, and Puay Leng Lee, and Zhimei Li, and Xia Jiang, and Sridhar Santhanakrishnan, and Tiong Wei Tan, and Yi Ling Goh, and Sze Yue Wong, and Haiyan Yang, and Esther H Q Ong, and Jeffrey Hill, and Qiang Yu, and Christina L L Chai
August 2000, Archives of pharmacal research,
Copied contents to your clipboard!